 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
September 16, 2012 10:13 AM
|
Journal of the American Academy of Physician AssistantsRemembering Uncle JohnnieHuffington Post (blog)My name is Bree Person, I have sickle-cell anemia, and I've had it since the day I was born -- 17 years ago.
|
|
Scooped by
Gilbert C FAURE
September 15, 2012 3:15 PM
|
Typically, peripheral mast cells exceed 10% of all nucleated cells; however, aleukemic variants exist and are characterized by less than 10% in the blood and more than 20% MC in the bone marrow. MC morphology has been ...
|
|
Scooped by
Gilbert C FAURE
September 15, 2012 3:11 PM
|
Adjuvant Chemotherapy Does Not Increase Risk of Acute Myeloid Leukemia and ...Equities.comThe innovative study titled, "Risk of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after adjuvant chemotherapy (CT) for early breast cancer...
|
|
Scooped by
Gilbert C FAURE
September 14, 2012 9:23 AM
|
New #podcast is an interview with Dr.Tom Loughran and patient he treated for #LGL large granular lymphocyte #leukemia http://t.co/Vr7ixsNa...
|
|
Scooped by
Gilbert C FAURE
September 12, 2012 3:27 PM
|
RT @ASH_hematology: #SickleCellAwareness: ASH continues its commitment to new rsch, treatments & access to care: http://t.co/HiqKIoMM...
|
|
Scooped by
Gilbert C FAURE
September 12, 2012 2:17 PM
|
PubMed comprises more than 22 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
|
Scooped by
Gilbert C FAURE
September 12, 2012 2:11 PM
|
Neal S. Young is now considered a world expert on bone-marrow-failure diseases.
|
|
Scooped by
Gilbert C FAURE
September 11, 2012 6:26 AM
|
|
|
Scooped by
Gilbert C FAURE
September 8, 2012 4:20 AM
|
The Leukemia & Lymphoma Society Awards Four Major Grants to Acclaimed ...Sacramento BeeDr.
|
|
Scooped by
Gilbert C FAURE
September 8, 2012 3:41 AM
|
Results from a recent Italian study confirm that smoldering myeloma patients with at least 60 percent of the cells in ...
|
|
Scooped by
Gilbert C FAURE
September 6, 2012 3:55 AM
|
BD Reagents for Blood Cell Disorders Part of the building blocks to support patient care for blood cell disorders, BD Biosciences reagents provide a full spectrum of color choices, allowing you to analyze multiple parameters ...
|
|
Scooped by
Gilbert C FAURE
September 6, 2012 3:49 AM
|
RT @werkwinkelAMC: Job opening: PhD Student “Immunoglobulin gene recombinations in leukemia and lymphoma” (http://t.co/Vo2vXAfV)...
|
|
Scooped by
Gilbert C FAURE
September 6, 2012 3:36 AM
|
Fanconi anemia is a recessive genetic disorder affecting 1 in 350,000 babies, which leaves cells unable to repair damaged DNA.
|
|
|
Scooped by
Gilbert C FAURE
September 16, 2012 10:10 AM
|
Uploaded and shared in Youtube by: mayoclinic — Hematologist Ruben Mesa, M.D., Chair, Division of Hematology and Oncology at Mayo Clinic in Arizona, discusses Myelofibrosis.
|
|
Scooped by
Gilbert C FAURE
September 15, 2012 3:14 PM
|
Genetic Engineering NewsEnd-Running Cancer Resistance to Targeted TherapiesGenetic Engineering News(Page 1 of 1).
|
|
Scooped by
Gilbert C FAURE
September 15, 2012 3:10 PM
|
Researchers find novel predictor for MDS progression riskMedical XpressD., Ph.D., senior member of Moffitt's Immunology Department.
|
|
Scooped by
Gilbert C FAURE
September 12, 2012 3:27 PM
|
Free #BloodJournal:High expression of lymphoid enhancer-binding factor-1 novel prognostic factor in AML #leukemia http://t.co/ghjLRhib...
|
|
Scooped by
Gilbert C FAURE
September 12, 2012 3:26 PM
|
Oncology Medical Article: Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial (Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA ...
|
|
Scooped by
Gilbert C FAURE
September 12, 2012 2:12 PM
|
From Luis Villela, M.D.,M.Sc. (The hemato-oncologist Corner is out!
|
|
Scooped by
Gilbert C FAURE
September 11, 2012 11:31 AM
|
Cellceutix Corporation (OTCBB: CTIX) (the “Company”), a clinical stage biopharmaceutical company focused on discovering small molecule drugs for...
|
|
Scooped by
Gilbert C FAURE
September 8, 2012 10:18 AM
|
PubMed comprises more than 22 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
|
Scooped by
Gilbert C FAURE
September 8, 2012 4:20 AM
|
Leukemia & Lymphoma Society awards SCOR program grant to Walter and ...News-Medical.net"Our bodies make billions of blood cells every day, and, to make room, billions of other blood cells must undergo apoptosis," Professor Adams said.
|
|
Scooped by
Gilbert C FAURE
September 6, 2012 3:06 PM
|
Advance registration ends 2day for ASH Symposium:Recent Advances in #Bloodcancer w/Focus on #Thrombosis on 9/28-29 http://t.co/7cCCthdq...
|
|
Scooped by
Gilbert C FAURE
September 6, 2012 3:55 AM
|
Epizyme commences EPZ-5676 Phase 1 study for MLL-r leukemiaNews-Medical.netEpizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, announced today that it has...
|
|
Scooped by
Gilbert C FAURE
September 6, 2012 3:38 AM
|
Bridge Grant Program Award apps avail 9/7!
|
Scoop.it!
